@PabloTorre As a UP grad, I also found the occasion and way you wore the sablay a bit off but you've responded to the controversy in such a classy way. No harm, no foul. Glad people had this conversation.
Quite the day in #MPX news! We describe cases post JYNNEOS in @JAMA_current. Nearly all <15 days after 1st dose, but we did identify a few cases >28days.
Take a peak at the number vaccinated, truly incredible work by everyone @howardbrownhc πͺπ½πͺπ½πͺπ½
https://t.co/vp7f7xchjX
@DouglasCaraba11@netw3rk All fiction is predicated on suspension of disbelief--acceptance of some implausibility as plausible. Why is a created world with skin color diversity so violently implausible that it stands in the way of a story about elves, dwarves and hobbits?
@drtimothyli@Cortes_Penfield @geno_md @IdVilchez Tedizolid maybe has a lower rate of AE. Data not great. I use them often for VAD infections in need of long-term suppression. Only 1 discontinuation for AE so far. For whatever it's worth.
MISADVENTURES IN AMERICAN HEALTHCARE
1. Doctor orders scan that's clearly indicated for patient & which they've had many times before (allowing for apples-to-apples comparison)
2. Despite order weeks in advance, receive denial day-before from insurer without any explanation
We love a stoplight table! Check out this great summary made by @moore_wjustin of PsA resistance π¦ to beta-lactams from the recent #Breakpoints discussion with @erinmccreary, @MaggieMonogue, and @aoliverp73. Then listen to the episode for all the details: https://t.co/ez0n3ae0fR
@dr_dmorgan@AdamRodmanMD@jbcarmody I had an attending in residency who would tease residents and students who present "past history of diabetes" by saying "Is it over?"
When I right out my note I use 'background/past medical history' as the section heading. Some issues are resolved and some are ongoing.
@drtimothyli Had pt w persistent MRSAB on VAN, DAP, CPT+DAP. Most recent isolate DAP NS. PET no target for source control. Tried CPT+TMP-SMX. BCx TTP slowed then cleared. Was it last combo or duration of tx on all these regimens? I don't know.
https://t.co/Ka4UfZHWyv
Are peer-to-peers for insurance approval/appeals EVER w actual peers (comparable clinical experience/expertise practicing in same field)? Or always w broadly medical employee of insurance company who have never treated someone like your pt?
Just curious.
@PBMazi I think it's a matter of institutional policy. I was told my chief residency yr would mean I would be labeled PGY5 in fellowship but paid PGY4. I have friends who were paid PGY5 at their fellowship institution because of their chief yr. π€·ββοΈ